news LMTK3 inhibitors could be an effective breast cancer therapy, say scientists 16 November 2020 | By Hannah Balfour (Drug Target Review) Researchers demonstrate that inhibiting the LMTK3 kinase is an effective anticancer strategy in murine models of breast cancer.
news Protective protein guards against DNA damage 5 August 2019 | By Rachael Harper (Drug Target Review) It has been discovered that Polo-like kinase (PLK1) guards against severe DNA damage and could help target fast-growing cancer cells.
news Discovery into cells’ energy supply could lead to targeted cancer treatment 16 January 2018 | By Dr Zara Kassam (Drug Target Review) Scientists have made a significant breakthrough in understanding how the molecular machines that produce key proteins are cleaned and maintained. ..